Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Document Type
Journal Article
Publication Date
7-28-2016
Journal
The New England Journal of Medicine
Volume
375
Issue
4
Inclusive Pages
323-334
DOI
10.1056/NEJMoa1515920
Keywords
Benzhydryl Compounds--therapeutic use; Diabetes Mellitus, Type 2--complications; Diabetic Nephropathies--drug therapy; Glucosides--therapeutic use; Hypoglycemic Agents--therapeutic use
APA Citation
Wanner, C., Inzucchi, S., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O., Woerle, H., Broedl, U., & Zinman, B. (2016). Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. The New England Journal of Medicine, 375 (4). http://dx.doi.org/10.1056/NEJMoa1515920
Peer Reviewed
1